UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 164

Sortiert nach

Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)

PLoS neglected tropical diseases, 2017-01, Vol.11 (1), p.e0005285-e0005285

2017

Volltextzugriff (PDF)

Optimal MHC-II-restricted tumor antigen presentation to CD4+ T helper cells: the key issue for development of anti-tumor vaccines

Journal of translational medicine, 2012-07, Vol.10 (1), p.154-154, Article 154

2012

Volltextzugriff (PDF)

Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1

Frontiers in immunology, 2017-05, Vol.8, p.564-564

2017

Volltextzugriff (PDF)

Fowlpoxvirus recombinants coding for the CIITA gene increase the expression of endogenous MHC-II and Fowlpox Gag/Pro and Env SIV transgenes

PloS one, 2018-01, Vol.13 (1), p.e0190869-e0190869

2018

Volltextzugriff (PDF)

Neonatal Fc receptor is involved in the protection of fibrinogen after its intake in peripheral blood mononuclear cells

Journal of translational medicine, 2018-03, Vol.16 (1), p.64-64, Article 64

2018

Volltextzugriff (PDF)

Major Histocompatibility Complex Class II Transactivator CIITA Is a Viral Restriction Factor That Targets Human T-Cell Lymphotropic Virus Type 1 Tax-1 Function and Inhibits Viral Replication

Journal of Virology, 2011-10, Vol.85 (20), p.10719-10729

2011

Volltextzugriff (PDF)

Tumor Immunology meets…Immunology: Modified cancer cells as professional APC for priming naïve tumor-specific CD4+ T cells

Oncoimmunology, 2017-01, Vol.6 (11), p.e1356149-e1356149

2017

Volltextzugriff (PDF)

Structural probing of Zn(II), Cd(II) and Hg(II) binding to human ubiquitin

Chemical communications (Cambridge, England), 2008-01 (45), p.5960-5962

2008

Volltextzugriff (PDF)

CIITA-Induced MHC Class II Expression in Mammary Adenocarcinoma Leads to a Th1 Polarization of the Tumor Microenvironment, Tumor Rejection, and Specific Antitumor Memory

Clinical cancer research, 2006-06, Vol.12 (11), p.3435-3443

2006

Volltextzugriff (PDF)

Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication

Journal of translational medicine, 2011-07, Vol.9 (1), p.106-106, Article 106

2011

Volltextzugriff (PDF)

MHC class II transactivator CIITA inhibits Tax-2-mediated HTLV-2 LTR transactivation and viral replication by binding to, and affecting Tax-2 intracellular localization

Retrovirology, 2011-06, Vol.8 (S1), p.A172-A172, Article A172

2011

Volltextzugriff (PDF)

Inhibition of Human T Cell Leukemia Virus Type 2 Replication by the Suppressive Action of Class II Transactivator and Nuclear Factor Y

Proceedings of the National Academy of Sciences - PNAS, 2006-08, Vol.103 (34), p.12861-12866

2006

Volltextzugriff (PDF)

The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-κB by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein

Journal of virology, 2016-04, Vol.90 (7), p.3708-3721

2016

Volltextzugriff (PDF)

The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T-Cell Lymphotropic Virus Type 1

Retrovirology, 2011-06, Vol.8 (S1), p.A171-A171, Article A171

2011

Volltextzugriff (PDF)

Major Histocompatibility Complex Class II Transcriptional Platform: Assembly of Nuclear Factor Y and Regulatory Factor X (RFX) on DNA Requires RFX5 Dimers

Molecular and Cellular Biology, 2002-08, Vol.22 (15), p.5616-5625

2002

Volltextzugriff (PDF)

A dual defensive role of CIITA against retroviral infections

Retrovirology, 2006-12, Vol.3 (S1), p.S102-S102, Article S102

2006

Volltextzugriff (PDF)

The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells

Journal of translational medicine, 2016-04, Vol.14 (94), p.94-94, Article 94

2016

Volltextzugriff (PDF)

Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL

Retrovirology, 2015-07, Vol.12 (1), p.59-59, Article 59

2015

Volltextzugriff (PDF)

Abstract B047: Adequate Antigen Availability (AAA) in antitumor immunity: Definition and consequences for novel strategies of tumor prevention and antitumor treatment

Cancer immunology research, 2016-01, Vol.4 (1_Supplement), p.B047-B047

2016

Volltextzugriff (PDF)

Proteomic analysis of dopamine and α‐synuclein interplay in a cellular model of Parkinson's disease pathogenesis

The FEBS journal, 2010-12, Vol.277 (23), p.4909-4919

2010

Volltextzugriff (PDF)

CIITA-driven MHC class II expressing tumor cells can efficiently prime naive CD4+ TH cells in vivo and vaccinate the host against parental MHC-II-negative tumor cells

Oncoimmunology, 2017-01, Vol.6 (1), p.e1261777-e1261777

2017

Volltextzugriff (PDF)

The MHC Class II Transactivator (CIITA): A "Physiologic" Drug Against HIV-1 Replication

Retrovirology, 2005-12, Vol.2 (S1), p.P2-P2, Article P2

2005

Volltextzugriff (PDF)

Corrigendum to “New vaccination strategies in liver cancer” [Cytokine Growth Factor Rev. 36 (2017) 125–129]

Cytokine & growth factor reviews, 2019-04, Vol.46, p.66-66

2019

Volltextzugriff (PDF)

Abstract B048: The MHC class II transactivator CIITA inhibits the persistent activation of NF-kB by Human T cell Lymphotropic Virus type-1 Tax-1 oncoprotein

Cancer immunology research, 2016-01, Vol.4 (1_Supplement), p.B048-B048

2016

Volltextzugriff (PDF)

Adequate Antigen Availability: A Key Issue for Novel Approaches to Tumor Vaccination and Tumor Immunotherapy

Journal of neuroimmune pharmacology, 2013-03, Vol.8 (1), p.28-36

2013

Volltextzugriff (PDF)

1 – 25 von 164

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(155)
Mit Volltextzugriff
(148)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)

Optimal MHC-II-restricted tumor antigen presentation to CD4+ T helper cells: the key issue for development of anti-tumor vaccines

Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1

Fowlpoxvirus recombinants coding for the CIITA gene increase the expression of endogenous MHC-II and Fowlpox Gag/Pro and Env SIV transgenes

Neonatal Fc receptor is involved in the protection of fibrinogen after its intake in peripheral blood mononuclear cells

Major Histocompatibility Complex Class II Transactivator CIITA Is a Viral Restriction Factor That Targets Human T-Cell Lymphotropic Virus Type 1 Tax-1 Function and Inhibits Viral Replication

Tumor Immunology meets…Immunology: Modified cancer cells as professional APC for priming naïve tumor-specific CD4+ T cells

Structural probing of Zn(II), Cd(II) and Hg(II) binding to human ubiquitin

CIITA-Induced MHC Class II Expression in Mammary Adenocarcinoma Leads to a Th1 Polarization of the Tumor Microenvironment, Tumor Rejection, and Specific Antitumor Memory

Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication

MHC class II transactivator CIITA inhibits Tax-2-mediated HTLV-2 LTR transactivation and viral replication by binding to, and affecting Tax-2 intracellular localization

Inhibition of Human T Cell Leukemia Virus Type 2 Replication by the Suppressive Action of Class II Transactivator and Nuclear Factor Y

The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-κB by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein

The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T-Cell Lymphotropic Virus Type 1

Major Histocompatibility Complex Class II Transcriptional Platform: Assembly of Nuclear Factor Y and Regulatory Factor X (RFX) on DNA Requires RFX5 Dimers

A dual defensive role of CIITA against retroviral infections

The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells

Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL

Abstract B047: Adequate Antigen Availability (AAA) in antitumor immunity: Definition and consequences for novel strategies of tumor prevention and antitumor treatment

Proteomic analysis of dopamine and α‐synuclein interplay in a cellular model of Parkinson's disease pathogenesis

CIITA-driven MHC class II expressing tumor cells can efficiently prime naive CD4+ TH cells in vivo and vaccinate the host against parental MHC-II-negative tumor cells

The MHC Class II Transactivator (CIITA): A "Physiologic" Drug Against HIV-1 Replication

Corrigendum to “New vaccination strategies in liver cancer” [Cytokine Growth Factor Rev. 36 (2017) 125–129]

Abstract B048: The MHC class II transactivator CIITA inhibits the persistent activation of NF-kB by Human T cell Lymphotropic Virus type-1 Tax-1 oncoprotein

Adequate Antigen Availability: A Key Issue for Novel Approaches to Tumor Vaccination and Tumor Immunotherapy

Suchergebnisse filtern